Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
1.460
+0.105 (7.75%)
At close: Oct 7, 2025, 4:00 PM EDT
1.540
+0.080 (5.48%)
After-hours: Oct 7, 2025, 7:58 PM EDT
Scinai Immunotherapeutics Market Cap
Scinai Immunotherapeutics has a market cap or net worth of $2.21 million as of October 7, 2025. Its market cap has decreased by -26.31% in one year.
Market Cap
2.21M
Enterprise Value
3.58M
1-Year Change
-26.31%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since May 12, 2015, Scinai Immunotherapeutics's market cap has decreased from $11.20M to $2.21M, a decrease of -80.26%. That is a compound annual growth rate of -14.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 2.10M | -27.59% |
| Dec 31, 2024 | 2.90M | 31.82% |
| Dec 29, 2023 | 2.20M | -60.00% |
| Dec 30, 2022 | 5.50M | -83.68% |
| Dec 31, 2021 | 33.70M | 5.64% |
| Dec 31, 2020 | 31.90M | -65.85% |
| Dec 31, 2019 | 93.40M | 199.36% |
| Dec 31, 2018 | 31.20M | 72.38% |
| Dec 29, 2017 | 18.10M | 60.18% |
| Dec 30, 2016 | 11.30M | 0.89% |
| Dec 31, 2015 | 11.20M | - |
| May 12, 2015 | 11.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |